rs542353221
Positions:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP3BP6_ModerateBS2
The ENST00000349945.7(NFAT5):βc.2691_2693delβ(p.Gln906del) variant causes a inframe deletion change. The variant allele was found at a frequency of 0.00136 in 1,614,070 control chromosomes in the GnomAD database, including 5 homozygotes. Variant has been reported in ClinVar as Likely benign (β ). Synonymous variant affecting the same amino acid position (i.e. Q897Q) has been classified as Likely benign.
Frequency
Genomes: π 0.0011 ( 0 hom., cov: 32)
Exomes π: 0.0014 ( 5 hom. )
Consequence
NFAT5
ENST00000349945.7 inframe_deletion
ENST00000349945.7 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.82
Genes affected
NFAT5 (HGNC:7774): (nuclear factor of activated T cells 5) The product of this gene is a member of the nuclear factors of activated T cells family of transcription factors. Proteins belonging to this family play a central role in inducible gene transcription during the immune response. This protein regulates gene expression induced by osmotic stress in mammalian cells. Unlike monomeric members of this protein family, this protein exists as a homodimer and forms stable dimers with DNA elements. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP3
Nonframeshift variant in repetitive region in ENST00000349945.7
BP6
Variant 16-69692513-TCAA-T is Benign according to our data. Variant chr16-69692513-TCAA-T is described in ClinVar as [Likely_benign]. Clinvar id is 456657.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 174 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFAT5 | NM_138713.4 | c.2691_2693del | p.Gln906del | inframe_deletion | 13/15 | ENST00000349945.7 | NP_619727.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NFAT5 | ENST00000349945.7 | c.2691_2693del | p.Gln906del | inframe_deletion | 13/15 | 1 | NM_138713.4 | ENSP00000338806 | A2 |
Frequencies
GnomAD3 genomes AF: 0.00115 AC: 175AN: 152104Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
175
AN:
152104
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00136 AC: 342AN: 250722Hom.: 1 AF XY: 0.00152 AC XY: 206AN XY: 135666
GnomAD3 exomes
AF:
AC:
342
AN:
250722
Hom.:
AF XY:
AC XY:
206
AN XY:
135666
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00139 AC: 2025AN: 1461848Hom.: 5 AF XY: 0.00140 AC XY: 1019AN XY: 727224
GnomAD4 exome
AF:
AC:
2025
AN:
1461848
Hom.:
AF XY:
AC XY:
1019
AN XY:
727224
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00114 AC: 174AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.00128 AC XY: 95AN XY: 74416
GnomAD4 genome
AF:
AC:
174
AN:
152222
Hom.:
Cov.:
32
AF XY:
AC XY:
95
AN XY:
74416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
NFAT5-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 01, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Immunodeficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at